15-89323504-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002693.3(POLG):c.2165G>A(p.Arg722His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000405 in 1,608,372 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002693.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLG | NM_002693.3 | c.2165G>A | p.Arg722His | missense_variant | 13/23 | ENST00000268124.11 | NP_002684.1 | |
POLG | NM_001126131.2 | c.2165G>A | p.Arg722His | missense_variant | 13/23 | NP_001119603.1 | ||
POLGARF | NM_001406557.1 | c.*1437G>A | 3_prime_UTR_variant | 13/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLG | ENST00000268124.11 | c.2165G>A | p.Arg722His | missense_variant | 13/23 | 1 | NM_002693.3 | ENSP00000268124.5 |
Frequencies
GnomAD3 genomes AF: 0.000788 AC: 120AN: 152192Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.000967 AC: 243AN: 251204Hom.: 3 AF XY: 0.000920 AC XY: 125AN XY: 135816
GnomAD4 exome AF: 0.000365 AC: 531AN: 1456062Hom.: 4 Cov.: 30 AF XY: 0.000371 AC XY: 269AN XY: 724828
GnomAD4 genome AF: 0.000788 AC: 120AN: 152310Hom.: 3 Cov.: 33 AF XY: 0.00122 AC XY: 91AN XY: 74488
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 20, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Progressive sclerosing poliodystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at